THE PHARMACEUTICAL INDUSTRY - A NEW PERSPECTIVE

A recession-resistant industry such as pharmaceuticals is undergoing a violent contraction cycle because of lack of new approved products, expiration of patents on existing blockbuster drugs, and the flood of generics. Ed Silverman, a noted journalist with the Star-Ledger has been tracking this industry on his blog, PHARMALOT. As of Saturday, April 5, 2008, the number of jobs these companies are expected to eliminate are:

1. Pfizer - 10,000
2. AstraZeneca - 7,600
3. Bayer - 6,100
4. Schering-Plough - 5,500
5. Wyeth - 5,000
6. Johnson & Johnson - 5,000
7. Bristol-Myers Squibb - 4,300
8. Novartis - 3,750
9. Amgen - 2,600
10. Glaxo - 1,650
11. King - 520
12. Sanofi-Aventis - 380
13. Sepracor - 300
14. Ligand Pharma - 267
15. PDL BioPharma - 250
16. West Pharma - 250
17. Abbott - 200
18. Bradley Pharma - 196
19. Alkermes - 150
20. Encysive Pharma - 150
21. Neurocrine Bio - 130
22, Nektar Thera - 110
23. Reliant Pharma -109

We will keep you posted on this blog as the numbers change significantly.

"Tough Times Never Last, But Tough People Do!"
Dr. Robert Schuller


So folks, hang in there during this so called 'recession.' Before we know it, it will be over. It too shall pass.
Don Sutaria, MS, IE (Prof.), PE
Founder, President & Life-Work Coach
CareerQuest